Evidence map›Paper›PMID 26823944›Full record

ReviewOxidative medicine and cellular longevity2016

Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel.

Inés Moret-Tatay, Marisa Iborra, Elena Cerrillo, Luis Tortosa, Pilar Nos, Belén Beltrán

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. MicroRNA-21 promotes epithelial-mesenchymal transition and migration of human bronchial epithelial cells by targeting poly (ADP-ribose) polymerase-1 and activating PI3K/AKT signaling.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Inés Moret-TatayInflammatory Bowel Disease Research Group, IIS Hospital La Fe, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain; CIBERehd, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain.
Marisa IborraInflammatory Bowel Disease Research Group, IIS Hospital La Fe, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain; CIBERehd, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain; Gastroenterology Department, La Fe University and Polytechnic Hospital, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain.
Elena CerrilloInflammatory Bowel Disease Research Group, IIS Hospital La Fe, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain; Gastroenterology Department, La Fe University and Polytechnic Hospital, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain.
Luis TortosaInflammatory Bowel Disease Research Group, IIS Hospital La Fe, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain; CIBERehd, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain.
Pilar NosInflammatory Bowel Disease Research Group, IIS Hospital La Fe, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain; CIBERehd, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain; Gastroenterology Department, La Fe University and Polytechnic Hospital, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain.
Belén BeltránInflammatory Bowel Disease Research Group, IIS Hospital La Fe, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain; CIBERehd, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain; Gastroenterology Department, La Fe University and Polytechnic Hospital, Avenida Fernado Abril Martorell, No. 106, 46026 Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESHospital Universitari i Politècnic La Fe · ESInstituto de Investigación Sanitaria La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) is an inflammatory disorder characterised by a transmural inflammation of the intestinal wall. Although the physiopathology of the disease is not yet fully understood, it is clear that the immune response plays an important role in it. This hyperreactive immune system is accompanied by the presence of unregulated reactive oxygen species (ROS). These elements are modulated in normal conditions by different elements, including enzymes that function as antioxidant defences preventing the harmful effects of ROS. However, in CD there is an imbalance between ROS production and these antioxidant elements, resulting in oxidative stress (OxS) phenomena. In fact, now OxS is being considered more a potential etiological factor for Crohn's disease rather than a concomitant effect in the disease. The persistence of the OxS can also be influencing the evolution of the disease. Furthermore, the epigenetic mechanisms, above all microRNAs, are being considered key elements in the pathogenesis of CD. These elements and the presence of OxS have also been linked to several diseases. We, therefore, describe in this review the most significant findings related to oxidative stress and microRNAs profiles in the peripheral blood of CD patients.

Indexed as

Oxidative StressAnimalsAntioxidantsBiomarkersCrohn DiseaseCytosolEpigenesis, GeneticFree RadicalsHumansInflammationIntestinal MucosaMicroRNAsReactive Oxygen SpeciesSignal TransductionAntioxidantsBiomarkersFree RadicalsMicroRNAsReactive Oxygen Species

Identifiers

PMID26823944
PMCPMC4707323
OpenAlexW2200524554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.